GENPACT LIMITED
GNYSECIK 1398659Industrials / Business Servicesfiscal year ends December70 quarters since 2009
Latest quarter Q3 FY2026, filed November 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
Share price
Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of November 6, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Nov 6, 2026 | Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026 | Q1 FY2026ended Mar 31, 2026filed May 8, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025 | Q1 FY2025ended Mar 31, 2025filed May 12, 2025 | Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,385 | 1,343 | 1,296 | 1,319 | 1,291 | 1,254 | 1,215 | 1,249 | +7.3% |
| Cost of revenue | 859 | 853 | 824 | 837 | 822 | 804 | 786 | 803 | +4.5% |
| Gross profit | 527 | 490 | 472 | 482 | 470 | 450 | 429 | 446 | +12.1% |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 312 | 294 | 270 | 277 | 262 | 266 | 241 | 249 | +19.2% |
| Operating income | 211 | 193 | 199 | 195 | 192 | 179 | 184 | 190 | +10.1% |
| Other income (expense) | 1 | 11 | 0 | 3 | 7 | 10 | 2 | 5 | −84.8% |
| Pretax income | 196 | 191 | 194 | 189 | 189 | 177 | 175 | 183 | +3.8% |
| Income tax | 45 | 45 | 46 | 46 | 44 | 44 | 44 | 41 | +2.9% |
| Net income | 152 | 146 | 148 | 143 | 146 | 133 | 131 | 142 | +4.0% |
| Diluted EPS ($) | 0.89 | 0.86 | 0.86 | — | 0.83 | 0.75 | 0.73 | — | +7.2% |
| Diluted shares (millions) | 170 | 170 | 173 | — | 176 | 177 | 178 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Nov 6, 2026 | Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026 | Q1 FY2026ended Mar 31, 2026filed May 8, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025 | Q1 FY2025ended Mar 31, 2025filed May 12, 2025 | Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 499 | 517 | 578 | 854 | 741 | 663 | 562 | 648 | −32.6% |
| Short-term investments | 0 | 0 | 350 | 350 | 0 | 0 | 0 | 23 | — |
| Total current assets | 2,338 | 2,171 | 2,405 | 2,656 | 2,212 | 2,135 | 1,943 | 2,080 | +5.7% |
| Total assets | 5,639 | 5,413 | 5,617 | 5,843 | 5,364 | 5,308 | 4,895 | 4,987 | +5.1% |
| Total current liabilities | 1,199 | 1,088 | 1,426 | 1,602 | 1,462 | 1,392 | 792 | 964 | −18.0% |
| Long-term debt | 1,148 | 1,154 | 1,160 | 1,166 | 827 | 833 | 1,189 | 1,195 | +38.8% |
| Total debt | 1,174 | 1,180 | 1,536 | 1,542 | 1,203 | 1,294 | 1,215 | 1,221 | −2.4% |
| Total liabilities | 2,931 | 2,808 | 3,142 | 3,294 | 2,820 | 2,721 | 2,442 | 2,598 | +3.9% |
| Stockholders’ equity | 2,709 | 2,605 | 2,475 | 2,549 | 2,545 | 2,587 | 2,453 | 2,390 | +6.4% |
| Shares outstanding (millions) | 167 | 168 | 170 | 170 | 172 | 174 | 175 | 176 | — |
Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Nov 6, 2026 | Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026 | Q1 FY2026ended Mar 31, 2026filed May 8, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025 | Q1 FY2025ended Mar 31, 2025filed May 12, 2025 | Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 93 | 72 | (24) | 287 | 308 | 177 | 40 | 203 | −69.8% |
| Capital expenditures | 17 | 14 | 24 | 18 | 16 | 22 | 22 | 20 | +2.2% |
| Free cash flow (CFO − capex) | 76 | 59 | (47) | 269 | 292 | 155 | 18 | 184 | −73.8% |
| Depreciation and amortization | 21 | 21 | 21 | 26 | 26 | 22 | 21 | 24 | −18.5% |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Dividends paid | 31 | 32 | 32 | 29 | 29 | 30 | 30 | 27 | +7.3% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 26, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 26, 2026 | FY2024ended Dec 31, 2024filed Mar 3, 2025 | FY2023ended Dec 31, 2023filed Feb 29, 2024 | FY2022ended Dec 31, 2022filed Mar 1, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed Mar 1, 2021 | FY2019ended Dec 31, 2019filed Mar 2, 2020 | FY2018ended Dec 31, 2018filed Mar 1, 2019 | FY2017ended Dec 31, 2017filed Mar 1, 2018 | FY2016ended Dec 31, 2016filed Mar 1, 2017 | FY2015ended Dec 31, 2015filed Feb 26, 2016 | FY2014ended Dec 31, 2014filed Feb 27, 2015 | FY2013ended Dec 31, 2013filed Feb 28, 2014 | FY2012ended Dec 31, 2012filed Mar 1, 2013 | FY2011ended Dec 31, 2011filed Feb 29, 2012 | FY2010ended Dec 31, 2010filed Mar 1, 2011 | FY2009ended Dec 31, 2009filed Aug 9, 2010 | FY2008ended Dec 31, 2008filed Aug 9, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,080 | 4,767 | 4,477 | 4,371 | 4,022 | 3,709 | 3,521 | 3,001 | 2,737 | 2,571 | 2,461 | 2,279 | 2,132 | 1,902 | 1,600 | 1,259 | 1,120 | 1,041 |
| Cost of revenue | 3,249 | 3,077 | 2,906 | 2,835 | 2,590 | 2,418 | 2,295 | 1,922 | 1,681 | 1,554 | 1,494 | 1,378 | 1,320 | 1,158 | 1,005 | 789 | 673 | 619 |
| Gross profit | 1,831 | 1,690 | 1,571 | 1,536 | 1,432 | 1,291 | 1,226 | 1,079 | 1,055 | 1,016 | 967 | 901 | 812 | 744 | 596 | 470 | 447 | 422 |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 1,047 | 967 | 913 | 938 | 866 | 790 | 795 | 694 | 689 | 653 | 608 | 586 | 485 | 457 | 358 | 282 | 265 | 255 |
| Operating income | 750 | 702 | 631 | 502 | 509 | 439 | 429 | 348 | 331 | 341 | 334 | 294 | 310 | 264 | 216 | 178 | 162 | 134 |
| Other income (expense) | 22 | 19 | 15 | 0 | 13 | 3 | 6 | 36 | 24 | 10 | 4 | 2 | (24) | (14) | 11 | 5 | 4 | 7 |
| Pretax income | 730 | 677 | 602 | 465 | 483 | 400 | 399 | 362 | 321 | 330 | 302 | 250 | 306 | 263 | 262 | 184 | 161 | 144 |
| Income tax | 178 | 163 | (29) | 112 | 114 | 92 | 95 | 81 | 60 | 62 | 62 | 57 | 71 | 78 | 71 | 34 | 25 | 9 |
| Net income | 552 | 514 | 631 | 353 | 369 | 308 | 305 | 282 | 263 | 270 | 240 | 192 | 230 | 178 | 184 | 142 | 127 | 125 |
| Diluted EPS ($) | 3.13 | 2.85 | 3.41 | 1.88 | 1.91 | 1.57 | 1.56 | 1.45 | 1.34 | 1.28 | 1.09 | 0.85 | 0.97 | 0.78 | 0.81 | 0.63 | 0.58 | 0.57 |
| Diluted shares (millions) | 177 | 180 | 185 | 188 | 193 | 196 | 195 | 194 | 197 | 210 | 219 | 225 | 236 | 230 | 226 | 225 | 220 | 218 |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 26, 2026 | FY2024ended Dec 31, 2024filed Mar 3, 2025 | FY2023ended Dec 31, 2023filed Feb 29, 2024 | FY2022ended Dec 31, 2022filed Mar 1, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed Mar 1, 2021 | FY2019ended Dec 31, 2019filed Mar 2, 2020 | FY2018ended Dec 31, 2018filed Mar 1, 2019 | FY2017ended Dec 31, 2017filed Mar 1, 2018 | FY2016ended Dec 31, 2016filed Mar 1, 2017 | FY2015ended Dec 31, 2015filed Feb 26, 2016 | FY2014ended Dec 31, 2014filed Feb 27, 2015 | FY2013ended Dec 31, 2013filed Feb 28, 2014 | FY2012ended Dec 31, 2012filed Mar 1, 2013 | FY2011ended Dec 31, 2011filed Feb 29, 2012 | FY2010ended Dec 31, 2010filed Mar 1, 2011 | FY2009ended Dec 31, 2009filed Aug 9, 2010 | FY2008ended Dec 31, 2008filed Aug 9, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 854 | 648 | 584 | 647 | 899 | 680 | 467 | 368 | 504 | 423 | 451 | 462 | 571 | 459 | 408 | 404 | 289 | 184 |
| Short-term investments | 350 | 23 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | 2,656 | 2,080 | 1,892 | 1,779 | 1,922 | 1,749 | 1,552 | 1,355 | 1,434 | 1,227 | 1,195 | 1,189 | 1,276 | 1,129 | 985 | 936 | 846 | — |
| Total assets | 5,843 | 4,987 | 4,806 | 4,589 | 4,975 | 4,874 | 4,454 | 3,529 | 3,450 | 2,886 | 2,793 | 2,743 | 2,689 | 2,606 | 2,403 | 1,893 | 1,748 | — |
| Total current liabilities | 1,602 | 964 | 1,318 | 1,103 | 1,309 | 1,203 | 910 | 976 | 839 | 731 | 594 | 622 | 462 | 518 | 662 | 323 | 396 | — |
| Long-term debt | 1,166 | 1,195 | 825 | 1,249 | 1,272 | 1,307 | 1,340 | 976 | 1,007 | 698 | 737 | 649 | 654 | 657 | 74 | 25 | 25 | — |
| Total debt | 1,542 | 1,221 | 1,267 | 1,426 | 1,656 | 1,591 | 1,443 | 1,304 | 1,216 | 897 | 798 | 789 | 658 | 742 | 355 | 25 | 70 | — |
| Total liabilities | 3,294 | 2,598 | 2,557 | 2,763 | 3,078 | 3,039 | 2,765 | 2,125 | 2,021 | 1,595 | 1,489 | 1,457 | 1,365 | 1,434 | 968 | 412 | 548 | — |
| Stockholders’ equity | 2,549 | 2,390 | 2,248 | 1,826 | 1,897 | 1,834 | 1,689 | 1,404 | 1,424 | 1,287 | 1,304 | 1,285 | 1,323 | 1,168 | 1,433 | 1,479 | 1,197 | — |
| Shares outstanding (millions) | 170 | 176 | 181 | 184 | 185 | 188 | 190 | 189 | 193 | 199 | 211 | 220 | 232 | 227 | 222 | 221 | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 26, 2026 | FY2024ended Dec 31, 2024filed Mar 3, 2025 | FY2023ended Dec 31, 2023filed Feb 29, 2024 | FY2022ended Dec 31, 2022filed Mar 1, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed Mar 1, 2021 | FY2019ended Dec 31, 2019filed Mar 2, 2020 | FY2018ended Dec 31, 2018filed Mar 1, 2019 | FY2017ended Dec 31, 2017filed Mar 1, 2018 | FY2016ended Dec 31, 2016filed Mar 1, 2017 | FY2015ended Dec 31, 2015filed Feb 26, 2016 | FY2014ended Dec 31, 2014filed Feb 27, 2015 | FY2013ended Dec 31, 2013filed Feb 28, 2014 | FY2012ended Dec 31, 2012filed Mar 1, 2013 | FY2011ended Dec 31, 2011filed Feb 29, 2012 | FY2010ended Dec 31, 2010filed Mar 1, 2011 | FY2009ended Dec 31, 2009filed Aug 9, 2010 | FY2008ended Dec 31, 2008filed Aug 9, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 813 | 615 | 491 | 444 | 694 | 584 | 428 | 340 | 359 | 346 | — | 272 | 312 | 311 | 267 | 163 | 158 | 211 |
| Capital expenditures | 78 | 83 | 55 | 51 | 53 | 70 | 75 | 85 | 57 | 82 | 62 | 63 | 49 | 83 | 36 | 55 | 53 | 62 |
| Free cash flow (CFO − capex) | 735 | 533 | 435 | 393 | 641 | 514 | 353 | 255 | 302 | 264 | — | 209 | 263 | 227 | 231 | 108 | 106 | 149 |
| Depreciation and amortization | 95 | 96 | 104 | 130 | 168 | 160 | 129 | 104 | 95 | 82 | 83 | 80 | 76 | 79 | 78 | 74 | 80 | 92 |
| Share repurchases | — | 253 | 225 | 214 | 298 | 137 | 30 | 154 | 220 | 345 | 227 | 303 | — | — | — | — | — | — |
| Dividends paid | 118 | 108 | 100 | 92 | 80 | 74 | 65 | 57 | 47 | — | — | — | — | — | — | — | — | — |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Mehta Piyush | Senior Vice President and CHRO | option exercise | 200,000 | $27.70 | $6M | 356,823 | Nov 13, 2026 |
| Nov 10, 2026 | Mehta Piyush | Senior Vice President and CHRO | open-market sale | 200,000 | $43.05 | $9M | 156,823 | Nov 13, 2026 |
| Nov 9, 2026 | Lindstrom Carol | Director | open-market sale | 2,364 | $42.56 | $101K | 25,342 | Nov 12, 2026 |
| Sep 14, 2026 | Kalra Balkrishan | President and CEO, Director | open-market sale | 10,000 | $36.79 | $368K | 501,114 | Sep 16, 2026 |
| Sep 9, 2026 | Pandit Sumita | Chief Financial Officer | award | 76,713 | $0.00 | — | 76,713 | Sep 11, 2026 |
| Aug 19, 2026 | Nanduru Anil | Senior Vice President | open-market sale | 6,191 | $37.03 | $229K | 70,253 | Aug 20, 2026 |
| Aug 14, 2026 | Dewan Sameer | Senior Vice President | open-market sale | 1,654 | $34.10 | $56K | 56,011 | Aug 18, 2026 |
| Aug 14, 2026 | Dewan Sameer | Senior Vice President | open-market sale | 13,318 | $34.10 | $454K | 42,693 | Aug 18, 2026 |
| Aug 13, 2026 | Weiner Michael Hal | Chief Financial Officer | open-market sale | 5,900 | $34.04 | $201K | 176,027 | Aug 14, 2026 |
| Aug 12, 2026 | Nanduru Anil | Senior Vice President | open-market sale | 11,852 | $33.92 | $402K | 76,444 | Aug 13, 2026 |
| Aug 11, 2026 | Nanduru Anil | Senior Vice President | open-market sale | 17,243 | $33.96 | $586K | 88,296 | Aug 13, 2026 |
| Apr 23, 2026 | Hinshaw John M | Director | award | 6,521 | $0.00 | — | 8,855 | Apr 27, 2026 |
| Apr 23, 2026 | Morken CeCelia | Director | award | 6,521 | $0.00 | — | 64,281 | Apr 27, 2026 |
| Apr 23, 2026 | Lindstrom Carol | Director | award | 6,521 | $0.00 | — | 27,706 | Apr 27, 2026 |
| Apr 23, 2026 | Gangestad Nicholas C | Director | award | 6,521 | $0.00 | — | 15,334 | Apr 27, 2026 |
| Apr 23, 2026 | Subaiya Thimaya K. | Director | award | 6,521 | $0.00 | — | 8,541 | Apr 27, 2026 |
| Apr 23, 2026 | Verdi Mark A | Director | award | 6,521 | $0.00 | — | 71,526 | Apr 27, 2026 |
| Apr 23, 2026 | Stevens Brian Mark | Director | award | 6,521 | $0.00 | — | 36,619 | Apr 27, 2026 |
| Apr 23, 2026 | Conigliaro Laura | Director | award | 6,521 | $0.00 | — | 79,337 | Apr 27, 2026 |
| Apr 23, 2026 | Madden James C. | Director | award | 9,999 | $0.00 | — | 73,067 | Apr 27, 2026 |
| Mar 10, 2026 | Weiner Michael Hal | Chief Financial Officer | tax withholding | 7,019 | $38.92 | $273K | 181,874 | Mar 12, 2026 |
| Mar 10, 2026 | Vashisht Riju | Senior Vice President | tax withholding | 7,080 | $38.92 | $276K | 123,668 | Mar 12, 2026 |
| Mar 10, 2026 | Nanduru Anil | Senior Vice President | tax withholding | 7,663 | $38.92 | $298K | 105,539 | Mar 12, 2026 |
| Mar 10, 2026 | Mehta Piyush | Senior Vice President and CHRO | tax withholding | 5,702 | $38.92 | $222K | 156,485 | Mar 12, 2026 |
| Mar 10, 2026 | Dewan Sameer | Senior Vice President | tax withholding | 3,542 | $38.92 | $138K | 57,665 | Mar 12, 2026 |
Full insider history for GENPACT LIMITED, or insider activity across all companies. A record of filings, not a recommendation.
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- GENPACT LIMITED, CIK 1398659 on EDGAR
- Extract generated
- November 16, 2026
- Withheld
- 1 line-years whose four quarters do not sum to the filed year: other income FY2015
- Repaired
- 2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2012, other income FY2022
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueServicesNetCostOfRevenueGrossProfitSellingGeneralAndAdministrativeExpenseOperatingIncomeLossNonoperatingIncomeExpense, OtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueShortTermInvestmentsAssetsCurrentAssetsLiabilitiesCurrentLongTermDebt, LongTermDebtNoncurrentLongTermDebt, LongTermDebt+short-term, noncurrent+current+short-termLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipmentPaymentsForRepurchaseOfCommonStockPaymentsOfDividends, PaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated November 16, 2026.
- JSON file
/data/financials/G.json